Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
American Heart Journal|September 18, 2025
Risk-guided disease management to prevent heart failure in adult cancer survivors of previous cardiotoxic cancer treatments: Baseline results of the REDEEM trialJoshua Wong, Joel Smith, Cheng Hwee Soh, et al.International Journal of Radiation Oncology, Biology, Physics|June 25, 2022
Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for OligometastasesShankar Siva, Gavin Jones, Mathias Bressel, et al.European Journal of Clinical Nutrition|November 29, 2024
Sociodemographic and clinical factors associated with low muscle mass and composition in people treated with (chemo)radiotherapy for lung cancerNicole Kiss, Carla M Prado, Gavin Abbott, et al.The Lancet. Oncology|February 17, 2019
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trialDavid Ball, G Tao Mai, Shalini Vinod, et al.International Journal of Radiation Oncology, Biology, Physics|June 3, 2023
Central Endocrine Complications Among Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive ReviewGreg Wheeler, Clemens Grassberger, Josephine Samers, et al.The Lancet. Oncology|October 3, 2006
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar, Murali Chintagumpala, David Ashley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.Pageof 4